CompletedNot Applicable

Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients

Turkey (Türkiye)80 participantsStarted 2017-06-28

Plain-language summary

Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .

Who can participate

Age range17 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: the patients with PCOS Exclusion Criteria: Cushing's syndrome 21-hydroxylase deficiency Congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinemia Diabetes Chronic cardiovascular Hepatic, renal, and hematologic diseases Malignancies Using oral contraceptives, anti-androgens, glucocorticoids, anti-hypertensives, anti-diabetics, calcium supplements and anti-obesity drugs and those who smoke or consume alcohol \-

What they're measuring

Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients

Timeframe: six months

Trial details

NCT IDNCT03587415

SponsorRecep Tayyip Erdogan University Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-11-30

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials